Stay updated on Empagliflozin Effects on Diuresis in Acute Decompensated HF Clinical Trial
Sign up to get notified when there's something new on the Empagliflozin Effects on Diuresis in Acute Decompensated HF Clinical Trial page.

Latest updates to the Empagliflozin Effects on Diuresis in Acute Decompensated HF Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe webpage has been updated to include details about a new clinical study on Acute Decompensated Heart Failure, specifically focusing on the use of empagliflozin (Jardiance®) as a treatment. Key information about the study's design, medications, and collaborators has been added, while extensive background information on heart failure has been removed.SummaryDifference43%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check87 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference1%
- Check94 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to Empagliflozin Effects on Diuresis in Acute Decompensated HF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Empagliflozin Effects on Diuresis in Acute Decompensated HF Clinical Trial page.